Abstracts tagged "Native Americans"

Abstract Number: 222 • 2017 ACR/ARHP Annual Meeting
Characterization of Unexpected Autoantibody Specificities in American Indian SLE Patients
Joseph M. Kheir¹, Tim Gross¹, Carla J. Guthridge¹, Krista Bean¹, Virginia C. Roberts¹, Joel M. Guthridge², M. Sohail Khan³, Fabio Mota⁴, Michael Peercy⁵, Bobby Saunkeah⁶ and Judith A. James⁷, ¹Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ³Cherokee Nation Health Services, Tahlequah, OK, ⁴Chickasaw Nation Medical Center, Ada, OK, ⁵Epidemiology, Chickasaw Nation Department of Health, Ada, OK, ⁶Chickasaw Nation Department of Health, Ada, OK, ⁷Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: System Lupus Erythematosus (SLE) is an autoimmune disease that is over-represented in the American Indian (AI) population and often manifests as a more severe…
Abstract Number: 228 • 2017 ACR/ARHP Annual Meeting
Characterizing Indigenous Community Engagement Patterns in Published Arthritis Studies: A Systematic Review of the Literature
Chu-Yang Lin¹, Kelle Hurd¹, Cheryl Barnabe² and Adalberto Loyola-Sánchez³, ¹University of Calgary, Calgary, AB, Canada, ²Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ³Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Indigenous populations in Canada, Australia, New Zealand and the United States of America have a higher prevalence of arthritis conditions and experience worse outcomes.…
Abstract Number: 1093 • 2017 ACR/ARHP Annual Meeting
Effectiveness of the Outreach Model for Rheumatology Specialty Clinics to On-Reserve First Nations in Canada: System-Level and Individual Measures of Performance and Outcomes
Sujay Nagaraj¹, Claire Barber², Margaret Kargard³, Tyler White³ and Cheryl Barnabe⁴, ¹McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, AB, Canada, ²Medicine, University of Calgary, Calgary, AB, Canada, ³Siksika Health Services, Siksika, AB, Canada, ⁴Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Background/Purpose: Inflammatory arthritis (IA) disproportionately affects Canada’s First Nations population. A Model of Care (MoC) consisting of rheumatology specialty services embedded in the primary care…
Abstract Number: 1169 • 2016 ACR/ARHP Annual Meeting
A Systematic Review of Rheumatic Disease Epidemiology in the Indigenous Populations of Canada, the United States, Australia and New Zealand
Cairistin McDougall¹, Kelle Hurd¹ and Cheryl Barnabe², ¹University of Calgary, Calgary, AB, Canada, ²Division of Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Two important reviews have summarized the epidemiology of rheumatic disease (Peschken 1999) and RA (Ferucci 2005) in Indigenous populations of North America. Our objective…
Abstract Number: 1250 • 2016 ACR/ARHP Annual Meeting
Mortality in Indigenous Populations of Canada, the United States, Australia, and New Zealand with Rheumatic Disease: A Systematic Review
Kelle Hurd¹ and Cheryl Barnabe², ¹University of Calgary, Calgary, AB, Canada, ²Division of Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Indigenous populations of Canada, America, Australia, and New Zealand share similar experiences of colonization impacting their rheumatic disease clinical outcomes. The objective of our…
Abstract Number: 115 • 2016 ACR/ARHP Annual Meeting
Early Inflammatory Arthritis Presentation, Management and Outcomes in Canadian Aboriginal Patients
Sujay Nagaraj¹, Cheryl Barnabe², Orit Schieir³, Vivian P. Bykerk⁴, Janet Pope⁵, Shahin Jamal⁶, Gilles Boire⁷, Edward Keystone⁸, Diane Tin⁹, Boulos Haraoui¹⁰, J Carter Thorne¹¹, Carol Hitchon¹² and Canadian Early Arthritis Cohort (CATCH) Investigators, ¹McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, AB, Canada, ²Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ³Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, ⁴Divison of Rheumatology, Hospital for Special Surgery, New York, NY, ⁵University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ⁶University of British Columbia, Vancouver, BC, Canada, ⁷Rheumatology Division, CHUS - Sherbrooke University, Sherbrooke, QC, Canada, ⁸Mt. Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ¹⁰Institute de Rheumatologie, Montreal, QC, Canada, ¹¹Southlake Regional Health Centre, Newmarket, ON, Canada, ¹²University of Manitoba, Winnipeg, MB, Canada
Background/Purpose: Differences in access to care that influence the timing and quality of treatment interventions may create outcome inequities for Aboriginal patients with inflammatory arthritis.…
Abstract Number: 3074 • 2015 ACR/ARHP Annual Meeting
The Shared Rheumatoid Arthritis HLA-DRB1 Susceptibility Epitope Shapes the Molecular Orientation of Citrulline and the Autoreactive T Cell Receptor Repertoire
Jurgen van Heemst¹, Stephen Scally², Soi Cheng Law³, Diane van der Woude⁴, Carol Hitchon⁵, David B. Robinson⁶, T. W. J. Huizinga⁷, Hugh H Reid⁸, René E. M. Toes⁷, Hani El-Gabalawy⁹, Jamie Rossjohn¹⁰ and Ranjeny Thomas¹¹, ¹Leiden University Medical Center, Leiden, Netherlands, ²Monash University, Melbourne, Australia, ³The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia, ⁴Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁵University of Manitoba, Winnipeg, MB, Canada, ⁶Arthritis Center, University of Manitoba, Winnipeg, MB, Canada, ⁷Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁸Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Melbourne, Australia, ⁹University of Manitoba Arthritis Center, Winnipeg, MB, Canada, ¹⁰Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff, England, ¹¹Translational Research Institute, The University of Queensland Diamantina Institute, Brisbane, Australia
Background/Purpose: Large-scale genomic studies have identified many genetic associations with autoimmune diseases, but the precise pathogenetic mechanisms by which the associated genes impact disease susceptibility…
Abstract Number: 2624 • 2014 ACR/ARHP Annual Meeting
Impact of Provider Specialty on the Diagnosis and Management of Systemic Lupus Erythematosus in the American Indian/Alaska Native Population
John McDougall Jr.¹, Charles G. Helmick², S. Sam Lim³, Caroline Gordon⁴ and Elizabeth Ferucci⁵, ¹Department of Internal Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, ³Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁴Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ⁵Alaska Native Medical Center, Anchorage, AK
Background/Purpose Systemic lupus erythematosus (SLE) is a complex disease that is traditionally diagnosed and managed by specialists, typically rheumatologists. Higher SLE prevalence in racial/ethnic minorities…
Abstract Number: 2401 • 2014 ACR/ARHP Annual Meeting
Interrupted and Delayed Care in First Nation Patients with Rheumatoid Arthritis: The Best Target for Therapy?
Liam O'Neil¹, Carol A. Hitchon², David B. Robinson³, Navjot Dhindsa¹, Hani El-Gabalawy³ and Christine A. Peschken⁴, ¹Medicine, University of Manitoba, Winnipeg, MB, Canada, ²Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ³Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada, ⁴University of Manitoba, Canada, Winnipeg, MB, Canada
Background/Purpose: Severe disease and poor outcomes have been described in First Nation (FN) patients with Rheumatoid Arthritis (RA). We examined the contributions of interrupted and…
Abstract Number: 2089 • 2014 ACR/ARHP Annual Meeting
The APOL1 Gene Is Not Associated with Lupus Nephritis in Individuals with Enriched Amerindian Ancestry
Julio Molineros¹, Hannah Ainsworth², Robert Kimberly³, Michelle Petri⁴, Rosalind Ramsey-Goldman⁵, Luis M. Vilá⁶, John D. Reveille^7,8, Elizabeth E. Brown⁹, Swapan Nath¹, Carl D. Langfeld¹⁰, Bernardo Pons-Estel on behalf of GENLES¹¹, Graciela S. Alarcon¹² and Marta E. Alarcon Riquelme¹, ¹Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Wake Forest, Winston-Salem, NC, ³University of Alabama, Birmingham, AL, ⁴Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Rheumatology, Northwestern University and Feinberg School of Medicine, Chicago, IL, ⁶Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, ⁷Internal Medicine/Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, ⁸Internal Medicine/Rheumatology, Univ of Texas Health Science Center at Houston, Houston, TX, ⁹University of Alabama at Birmingham, Birmingham, AL, ¹⁰Department of Biostatistics, Wake Forest University Health Sciences, Winston-Salem, NC, ¹¹Sanatorio Parque, Rosario, Argentina, ¹²Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
The APOL1 Gene is not Associated with Lupus Nephritis in Individuals with Enriched Amerindian AncestryBackground/Purpose: The APOL1 gene coding variants G1 and G2 have been…
Abstract Number: 2023 • 2014 ACR/ARHP Annual Meeting
Prevalence of Inflammatory Arthritis Conditions in the First Nations Population of Alberta
Cheryl Barnabe¹, C. Allyson Jones², Don Voaklander³, Deborah Marshall⁴, Christine Peschken⁵, Sasha Bernatsky⁶, John Esdaile⁷ and Brenda Hemmelgarn⁸, ¹Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ²Departments of Physical Therapy and School of Public Health, University of Alberta, Edmonton, AB, Canada, ³University of Alberta, Edmonton, AB, Canada, ⁴University of Calgary, Calgary, AB, Canada, ⁵Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ⁶Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ⁷Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁸Division of Nephrology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Canada's First Nations population reports higher rates of physician-diagnosed arthritis and rheumatism, and is known to have twice the rate of osteoarthritis. The prevalence…
Abstract Number: 2022 • 2014 ACR/ARHP Annual Meeting
First Nations Persons Have an Increased Risk of Developing Rheumatoid Arthritis with an Early Onset Age but Are Seen Less Frequently By Rheumatologists: A Population Based Study
Carol A. Hitchon¹, Sazzadul Khan², Brenda Elias³, Hani S. El-Gabalawy⁴, Alan Katz⁵ and Christine A. Peschken¹, ¹Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ²Manitoba Centre for Health Policy and Research, University of Manitoba, Winnipeg, MB, Canada, ³Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ⁴Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada, ⁵University of Manitoba, Winnipeg, MB, Canada
Background/Purpose High global prevalence rates of rheumatoid arthritis (RA) have been reported in First Nations (FN). For our regional population of 1.2 million, health care…
Abstract Number: 1855 • 2014 ACR/ARHP Annual Meeting
Not Keeping up with the Times: High Mortality and Early Death Due to Disease in North American Natives with Systemic Lupus Erythematosus (SLE)
Ripneet Puar¹, Carol A. Hitchon², David B. Robinson³, Hani El-Gabalawy³, Navjot Dhindsa¹ and Christine A. Peschken⁴, ¹Medicine, University of Manitoba, Winnipeg, MB, Canada, ²Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ³Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada, ⁴University of Manitoba, Canada, Winnipeg, MB, Canada
Background/Purpose: Reports in recent decades show drastic improvements in survival of SLE patients, with 10-15 year survival rates of >90%. However, little is known about…
Abstract Number: 1696 • 2013 ACR/ARHP Annual Meeting
Prevalence and Incidence of Systemic Lupus Erythematosus in a Population-Based Registry of American Indian and Alaska Native People in the United States, 2007-2009
Elizabeth D. Ferucci¹, Janet Johnston², Jasmine Gaddy³, Lisa Sumner⁴, James Posever⁴, Tammy L. Choromanski¹, Caroline Gordon⁵, S. Sam Lim⁶ and Charles G. Helmick⁷, ¹Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, AK, ²Institute for Circumpolar Health Studies, Univeristy of Alaska Anchorage, Anchorage, AK, ³Medicine/Rheumatology, Oklahoma City Area Indian Health Service, Oklahoma City, OK, ⁴Medicine/Rheumatology, Phoenix Indian Medical Center, Phoenix, AZ, ⁵Rheumatology Research Group (East Wing), School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom, ⁶Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁷National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Estimates of the prevalence and incidence of systemic lupus erythematosus (SLE) have varied widely but have consistently been high in women and minority…
Abstract Number: 96 • 2013 ACR/ARHP Annual Meeting
Epidemiology and Health Services Use For Osteoarthritis By First Nations People In Alberta, Canada
Cheryl Barnabe¹, Allyson Jones², Ed Enns³, Don Voaklander⁴, Christine Peschken⁵, Joanne Homik⁴, John Esdaile⁶, Sasha Bernatsky⁷, Brenda Hemmelgarn⁸ and Deborah Marshall⁹, ¹Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, ²Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, ³Alberta Bone and Joint Health Institute, Calgary, AB, Canada, ⁴University of Alberta, Edmonton, AB, Canada, ⁵Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ⁶Medicine, University of British Columbia, Vancouver, BC, Canada, ⁷Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, ⁸Division of Nephrology, University of Calgary, Calgary, AB, Canada, ⁹University of Calgary, Calgary, AB, Canada
Background/Purpose: Self-reported survey data and a single provincial administrative data source have previously indicated that the First Nations (FN) population in Canada has a 1.5…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].